Opus Genetics (IRD) Interest & Investment Income (2010 - 2020)
Opus Genetics' (IRD) quarterly Interest & Investment Income came in at $1774.0 in Q3 2020, down 97.74% year-on-year from $78534.0 in Q4 2019, and down 70.64% on a QoQ basis from $6042.0 in Q2 2020.
Opus Genetics (IRD) Interest & Investment Income (2010 - 2020) Analysis & Trends
Opus Genetics (IRD) has 11 years of Interest & Investment Income data on file, last reported at $1774.0 in Q3 2020.
- On a quarterly basis, Interest & Investment Income fell 97.74% year-over-year to $1774.0 in Q3 2020; TTM through Sep 2020 was $99365.0, a 68.21% decrease from a year earlier, with the FY2019 full-year figure at $313700.0, up 23.34% from the prior year.
- Interest & Investment Income for Q3 2020 stood at $1774.0, down from $6042.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for IRD reached as high as $96650.0 in Q2 2019 and fell as low as $1774.0 in Q3 2020.
- Historically, Interest & Investment Income has averaged $49255.1 across 5 years, with a median of $55153.0 in 2018.
- Across the five-year window, Interest & Investment Income soared 138.19% in 2018 and sank 97.74% in 2020, its largest moves.
- Year by year, Interest & Investment Income stood at $34681.0 in 2016, then surged by 106.67% to $71674.0 in 2017, then fell by 21.89% to $55982.0 in 2018, then gained by 2.05% to $57131.0 in 2019, then sank by 96.89% to $1774.0 in 2020.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $1774.0 in Q3 2020, $6042.0 in Q2 2020, and $34418.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1,774.00 |
| Jun 30, 2020 | 6,042.00 |
| Mar 31, 2020 | 34,418.00 |
| Dec 31, 2019 | 57,131.00 |
| Sep 30, 2019 | 78,534.00 |
| Jun 30, 2019 | 96,650.00 |
| Mar 31, 2019 | 81,385.00 |
| Dec 31, 2018 | 55,982.00 |
| Sep 30, 2018 | 55,153.00 |
| Jun 30, 2018 | 67,473.00 |
| Mar 31, 2018 | 75,736.00 |
| Dec 31, 2017 | 71,674.00 |
| Sep 30, 2017 | 60,750.00 |
| Jun 30, 2017 | 42,782.00 |
| Mar 31, 2017 | 31,797.00 |
| Dec 31, 2016 | 34,681.00 |
| Sep 30, 2016 | 26,145.00 |
| Jun 30, 2016 | 28,868.00 |
| Mar 31, 2016 | 28,871.00 |
| Dec 31, 2015 | 21,943.00 |